Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas

Distinguishing between peritoneal epithelioid mesotheliomas and papillary serous carcinomas involving the peritoneum can be difficult on routine histological preparations, but this differential diagnosis can be facilitated by the use of immunohistochemistry. Recent investigations have indicated that...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Modern pathology 2013-04, Vol.26 (4), p.553-562
1. Verfasser: Ordóñez, Nelson G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 562
container_issue 4
container_start_page 553
container_title Modern pathology
container_volume 26
creator Ordóñez, Nelson G
description Distinguishing between peritoneal epithelioid mesotheliomas and papillary serous carcinomas involving the peritoneum can be difficult on routine histological preparations, but this differential diagnosis can be facilitated by the use of immunohistochemistry. Recent investigations have indicated that PAX8, PAX2, claudin-4, and h-caldesmon are immunohistochemical markers that can assist in distinguishing between these two malignancies; however, much of the information published on the value of these markers is either insufficient or contradictory. The purpose of this study is to resolve some of the existing controversies and to fully determine the practical value of these markers for assisting in the differential diagnosis between peritoneal mesotheliomas and serous carcinomas. In order to do so, a total of 40 peritoneal epithelioid mesotheliomas and 45 serous carcinomas (15 primary, 30 metastatic to the peritoneum) were investigated. PAX8 and PAX2 nuclear positivity was demonstrated in 42 (93%) and 25 (56%) of the serous carcinomas, respectively, whereas none of the mesotheliomas expressed either marker. Forty-four (98%) of the serous carcinomas exhibited claudin-4 reactivity along the cell membrane, whereas none of the mesotheliomas were positive for this marker. All of the serous carcinomas and mesotheliomas were negative for h-caldesmon. Based on these results, it is concluded that PAX8 and claudin-4 have a higher sensitivity and specificity for assisting in discriminating between peritoneal epithelioid mesotheliomas and serous carcinomas when compared with all of the other positive carcinoma markers that are, at present, recommended to be included in the immunohistochemical panels used in this differential diagnosis. Even though it is highly specific, PAX2 has little practical value in the diagnosis of peritoneal epithelioid mesotheliomas as its sensitivity is low. The h-caldesmon is not useful.
doi_str_mv 10.1038/modpathol.2012.200
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1322731235</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0893395222020816</els_id><sourcerecordid>1322731235</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-d18e53e0a4e51e4cb7f901a84cb034c81b02aa0117da19bc356a5586aa7e455c3</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EotvCC3BAlrhw2LT-E28ciUtVUUCqRA-AuEWz9qTrKraDnSDxDn1oHKVUFYdexjPj3zce-SPkDWennEl95qMdYTrE4VQwLkpgz8iGK8kqJrR6TjZMt7KSrRJH5DjnW8Z4rbR4SY6E5O2uaesNufsBw4w09vT6_KfeLlFsqRlgti5U9ZZCsPRQGRgsZh8Ddd7PIeYJXHDhhrpArctTSWeXD0tnxOSmGBAGiqObDji46Cz1mONaeMi0T9HTjCnOmRpIxoWl_Yq86GHI-Pr-PCHfLz9-u_hcXX399OXi_KoydSOmynKNSiKDGhXH2uybvmUcdMmYrI3meyYAGOeNBd7ujVQ7UErvABqslTLyhLxf544p_poxT5132eAwQMCyUcelEI3kQqqCvvsPvY1zCmW7heKac93UhRIrZVLMOWHfjcl5SH86zrrFq-7Bq27xqgRWRG_vR897j_ZB8s-cAsgVyOUq3GB69PZTYz-sKiw_-NsVVTYOg0HrEpqps9E9Jf8LdBe5sA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1321811874</pqid></control><display><type>article</type><title>Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Ordóñez, Nelson G</creator><creatorcontrib>Ordóñez, Nelson G</creatorcontrib><description>Distinguishing between peritoneal epithelioid mesotheliomas and papillary serous carcinomas involving the peritoneum can be difficult on routine histological preparations, but this differential diagnosis can be facilitated by the use of immunohistochemistry. Recent investigations have indicated that PAX8, PAX2, claudin-4, and h-caldesmon are immunohistochemical markers that can assist in distinguishing between these two malignancies; however, much of the information published on the value of these markers is either insufficient or contradictory. The purpose of this study is to resolve some of the existing controversies and to fully determine the practical value of these markers for assisting in the differential diagnosis between peritoneal mesotheliomas and serous carcinomas. In order to do so, a total of 40 peritoneal epithelioid mesotheliomas and 45 serous carcinomas (15 primary, 30 metastatic to the peritoneum) were investigated. PAX8 and PAX2 nuclear positivity was demonstrated in 42 (93%) and 25 (56%) of the serous carcinomas, respectively, whereas none of the mesotheliomas expressed either marker. Forty-four (98%) of the serous carcinomas exhibited claudin-4 reactivity along the cell membrane, whereas none of the mesotheliomas were positive for this marker. All of the serous carcinomas and mesotheliomas were negative for h-caldesmon. Based on these results, it is concluded that PAX8 and claudin-4 have a higher sensitivity and specificity for assisting in discriminating between peritoneal epithelioid mesotheliomas and serous carcinomas when compared with all of the other positive carcinoma markers that are, at present, recommended to be included in the immunohistochemical panels used in this differential diagnosis. Even though it is highly specific, PAX2 has little practical value in the diagnosis of peritoneal epithelioid mesotheliomas as its sensitivity is low. The h-caldesmon is not useful.</description><identifier>ISSN: 0893-3952</identifier><identifier>EISSN: 1530-0285</identifier><identifier>DOI: 10.1038/modpathol.2012.200</identifier><identifier>PMID: 23196794</identifier><identifier>CODEN: MODPEO</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>631/67/1857 ; 692/699/67 ; 692/700/139 ; Antibodies ; Antigens ; Biomarkers, Tumor - analysis ; Calmodulin-Binding Proteins - analysis ; Cancer ; claudin-4 ; Claudin-4 - analysis ; Cystadenocarcinoma, Serous - diagnosis ; Diagnosis, Differential ; Female ; h-caldesmon ; Humans ; Immunohistochemistry ; Laboratory Medicine ; Male ; Medicine ; Medicine &amp; Public Health ; Mesothelioma ; Mesothelioma - diagnosis ; Metastasis ; original-article ; Paired Box Transcription Factors - analysis ; Pathology ; PAX2 ; PAX2 Transcription Factor - analysis ; PAX8 ; PAX8 Transcription Factor ; peritoneal mesothelioma ; Peritoneal Neoplasms - diagnosis ; Sensitivity and Specificity ; serous carcinoma</subject><ispartof>Modern pathology, 2013-04, Vol.26 (4), p.553-562</ispartof><rights>2013 United States &amp; Canadian Academy of Pathology</rights><rights>United States and Canadian Academy of Pathology, Inc. 2013</rights><rights>Copyright Nature Publishing Group Apr 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-d18e53e0a4e51e4cb7f901a84cb034c81b02aa0117da19bc356a5586aa7e455c3</citedby><cites>FETCH-LOGICAL-c472t-d18e53e0a4e51e4cb7f901a84cb034c81b02aa0117da19bc356a5586aa7e455c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23196794$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ordóñez, Nelson G</creatorcontrib><title>Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas</title><title>Modern pathology</title><addtitle>Mod Pathol</addtitle><addtitle>Mod Pathol</addtitle><description>Distinguishing between peritoneal epithelioid mesotheliomas and papillary serous carcinomas involving the peritoneum can be difficult on routine histological preparations, but this differential diagnosis can be facilitated by the use of immunohistochemistry. Recent investigations have indicated that PAX8, PAX2, claudin-4, and h-caldesmon are immunohistochemical markers that can assist in distinguishing between these two malignancies; however, much of the information published on the value of these markers is either insufficient or contradictory. The purpose of this study is to resolve some of the existing controversies and to fully determine the practical value of these markers for assisting in the differential diagnosis between peritoneal mesotheliomas and serous carcinomas. In order to do so, a total of 40 peritoneal epithelioid mesotheliomas and 45 serous carcinomas (15 primary, 30 metastatic to the peritoneum) were investigated. PAX8 and PAX2 nuclear positivity was demonstrated in 42 (93%) and 25 (56%) of the serous carcinomas, respectively, whereas none of the mesotheliomas expressed either marker. Forty-four (98%) of the serous carcinomas exhibited claudin-4 reactivity along the cell membrane, whereas none of the mesotheliomas were positive for this marker. All of the serous carcinomas and mesotheliomas were negative for h-caldesmon. Based on these results, it is concluded that PAX8 and claudin-4 have a higher sensitivity and specificity for assisting in discriminating between peritoneal epithelioid mesotheliomas and serous carcinomas when compared with all of the other positive carcinoma markers that are, at present, recommended to be included in the immunohistochemical panels used in this differential diagnosis. Even though it is highly specific, PAX2 has little practical value in the diagnosis of peritoneal epithelioid mesotheliomas as its sensitivity is low. The h-caldesmon is not useful.</description><subject>631/67/1857</subject><subject>692/699/67</subject><subject>692/700/139</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Calmodulin-Binding Proteins - analysis</subject><subject>Cancer</subject><subject>claudin-4</subject><subject>Claudin-4 - analysis</subject><subject>Cystadenocarcinoma, Serous - diagnosis</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>h-caldesmon</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mesothelioma</subject><subject>Mesothelioma - diagnosis</subject><subject>Metastasis</subject><subject>original-article</subject><subject>Paired Box Transcription Factors - analysis</subject><subject>Pathology</subject><subject>PAX2</subject><subject>PAX2 Transcription Factor - analysis</subject><subject>PAX8</subject><subject>PAX8 Transcription Factor</subject><subject>peritoneal mesothelioma</subject><subject>Peritoneal Neoplasms - diagnosis</subject><subject>Sensitivity and Specificity</subject><subject>serous carcinoma</subject><issn>0893-3952</issn><issn>1530-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kc9u1DAQxi0EotvCC3BAlrhw2LT-E28ciUtVUUCqRA-AuEWz9qTrKraDnSDxDn1oHKVUFYdexjPj3zce-SPkDWennEl95qMdYTrE4VQwLkpgz8iGK8kqJrR6TjZMt7KSrRJH5DjnW8Z4rbR4SY6E5O2uaesNufsBw4w09vT6_KfeLlFsqRlgti5U9ZZCsPRQGRgsZh8Ddd7PIeYJXHDhhrpArctTSWeXD0tnxOSmGBAGiqObDji46Cz1mONaeMi0T9HTjCnOmRpIxoWl_Yq86GHI-Pr-PCHfLz9-u_hcXX399OXi_KoydSOmynKNSiKDGhXH2uybvmUcdMmYrI3meyYAGOeNBd7ujVQ7UErvABqslTLyhLxf544p_poxT5132eAwQMCyUcelEI3kQqqCvvsPvY1zCmW7heKac93UhRIrZVLMOWHfjcl5SH86zrrFq-7Bq27xqgRWRG_vR897j_ZB8s-cAsgVyOUq3GB69PZTYz-sKiw_-NsVVTYOg0HrEpqps9E9Jf8LdBe5sA</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Ordóñez, Nelson G</creator><general>Elsevier Inc</general><general>Nature Publishing Group US</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20130401</creationdate><title>Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas</title><author>Ordóñez, Nelson G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-d18e53e0a4e51e4cb7f901a84cb034c81b02aa0117da19bc356a5586aa7e455c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>631/67/1857</topic><topic>692/699/67</topic><topic>692/700/139</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Calmodulin-Binding Proteins - analysis</topic><topic>Cancer</topic><topic>claudin-4</topic><topic>Claudin-4 - analysis</topic><topic>Cystadenocarcinoma, Serous - diagnosis</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>h-caldesmon</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mesothelioma</topic><topic>Mesothelioma - diagnosis</topic><topic>Metastasis</topic><topic>original-article</topic><topic>Paired Box Transcription Factors - analysis</topic><topic>Pathology</topic><topic>PAX2</topic><topic>PAX2 Transcription Factor - analysis</topic><topic>PAX8</topic><topic>PAX8 Transcription Factor</topic><topic>peritoneal mesothelioma</topic><topic>Peritoneal Neoplasms - diagnosis</topic><topic>Sensitivity and Specificity</topic><topic>serous carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ordóñez, Nelson G</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Modern pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ordóñez, Nelson G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas</atitle><jtitle>Modern pathology</jtitle><stitle>Mod Pathol</stitle><addtitle>Mod Pathol</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>26</volume><issue>4</issue><spage>553</spage><epage>562</epage><pages>553-562</pages><issn>0893-3952</issn><eissn>1530-0285</eissn><coden>MODPEO</coden><abstract>Distinguishing between peritoneal epithelioid mesotheliomas and papillary serous carcinomas involving the peritoneum can be difficult on routine histological preparations, but this differential diagnosis can be facilitated by the use of immunohistochemistry. Recent investigations have indicated that PAX8, PAX2, claudin-4, and h-caldesmon are immunohistochemical markers that can assist in distinguishing between these two malignancies; however, much of the information published on the value of these markers is either insufficient or contradictory. The purpose of this study is to resolve some of the existing controversies and to fully determine the practical value of these markers for assisting in the differential diagnosis between peritoneal mesotheliomas and serous carcinomas. In order to do so, a total of 40 peritoneal epithelioid mesotheliomas and 45 serous carcinomas (15 primary, 30 metastatic to the peritoneum) were investigated. PAX8 and PAX2 nuclear positivity was demonstrated in 42 (93%) and 25 (56%) of the serous carcinomas, respectively, whereas none of the mesotheliomas expressed either marker. Forty-four (98%) of the serous carcinomas exhibited claudin-4 reactivity along the cell membrane, whereas none of the mesotheliomas were positive for this marker. All of the serous carcinomas and mesotheliomas were negative for h-caldesmon. Based on these results, it is concluded that PAX8 and claudin-4 have a higher sensitivity and specificity for assisting in discriminating between peritoneal epithelioid mesotheliomas and serous carcinomas when compared with all of the other positive carcinoma markers that are, at present, recommended to be included in the immunohistochemical panels used in this differential diagnosis. Even though it is highly specific, PAX2 has little practical value in the diagnosis of peritoneal epithelioid mesotheliomas as its sensitivity is low. The h-caldesmon is not useful.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><pmid>23196794</pmid><doi>10.1038/modpathol.2012.200</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-3952
ispartof Modern pathology, 2013-04, Vol.26 (4), p.553-562
issn 0893-3952
1530-0285
language eng
recordid cdi_proquest_miscellaneous_1322731235
source MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects 631/67/1857
692/699/67
692/700/139
Antibodies
Antigens
Biomarkers, Tumor - analysis
Calmodulin-Binding Proteins - analysis
Cancer
claudin-4
Claudin-4 - analysis
Cystadenocarcinoma, Serous - diagnosis
Diagnosis, Differential
Female
h-caldesmon
Humans
Immunohistochemistry
Laboratory Medicine
Male
Medicine
Medicine & Public Health
Mesothelioma
Mesothelioma - diagnosis
Metastasis
original-article
Paired Box Transcription Factors - analysis
Pathology
PAX2
PAX2 Transcription Factor - analysis
PAX8
PAX8 Transcription Factor
peritoneal mesothelioma
Peritoneal Neoplasms - diagnosis
Sensitivity and Specificity
serous carcinoma
title Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T10%3A34%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Value%20of%20PAX8,%20PAX2,%20claudin-4,%20and%20h-caldesmon%20immunostaining%20in%20distinguishing%20peritoneal%20epithelioid%20mesotheliomas%20from%20serous%20carcinomas&rft.jtitle=Modern%20pathology&rft.au=Ord%C3%B3%C3%B1ez,%20Nelson%20G&rft.date=2013-04-01&rft.volume=26&rft.issue=4&rft.spage=553&rft.epage=562&rft.pages=553-562&rft.issn=0893-3952&rft.eissn=1530-0285&rft.coden=MODPEO&rft_id=info:doi/10.1038/modpathol.2012.200&rft_dat=%3Cproquest_cross%3E1322731235%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1321811874&rft_id=info:pmid/23196794&rft_els_id=S0893395222020816&rfr_iscdi=true